Only North American MDR-TB Drug Maker Closing After Five Years
April 27, 2010
An Indiana-based manufacturer of a treatment for multi-drug resistant tuberculosis is closing, the Associated Press/Indianapolis Business Journal reports. "The Purdue Research Foundation says the Chao Center for Industrial Pharmacy and Contract Manufacturing was unable to become self-sustaining in part because of the recession. The center ... reached an agreement with Eli Lilly and Co. in 2007 to become North America's sole maker of the tuberculosis drug Seromycin" (4/27).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.